Retrospective analysis evaluates HDR brachytherapy's efficacy and cosmetic outcomes for BCC and cSCC in nasal areas.
Background Basal cell carcinoma (BCC) and cutaneous squamous cell carcinoma (cSCC) are the most common non-melanoma skin cancers, frequently affecting the facial region. High-Dose Rate (HDR) interstitial brachytherapy (iBT) offers a promising alternative to surgery, particularly in cosmetically sensitive areas like the nasal region. This study evaluates the clinical efficacy and esthetic outcomes of HDR iBT in the treatment of nasal BCC and cSCC.
No takes yet. Share an insight, caveat, or question.
Ettalhaoui et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: